Phase II trial of the effects of interferon alfa-2b on the immunogenicity of a polyvalent melanoma antigen vaccine in patients with stage III malignant melanoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha-2b; Interleukin-2; Melanoma vaccine
- Indications Malignant melanoma
- Focus Therapeutic Use
- 31 Mar 2016 Biomarkers information updated
- 22 Jan 2011 Last checked against ClinicalTrials.gov record.
- 15 Oct 2005 New trial record.